Candriam S.C.A. Immuno Gen, Inc. Transaction History

Candriam S.C.A.

$17.1 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.46 - $29.95 $124 - $299	10 Added 0.0%	1,122,598 $33.3 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $1.83 Million - $2.58 Million	130,006 Added 13.1%	1,122,588 $17.8 Million
Q2 2023 Aug 08, 2023	SELL	$3.75 - $20.05 $5.24 Million - $28 Million	-1,396,714 Reduced 58.46%	992,582 $18.7 Million
Q1 2023 May 12, 2023	SELL	$3.67 - $4.92 $1.1 Million - $1.48 Million	-300,000 Reduced 11.16%	2,389,296 $9.17 Million
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $752,292 - $1.04 Million	-165,339 Reduced 5.79%	2,689,296 $13.3 Million
Q3 2022 Nov 10, 2022	BUY	$4.48 - $6.47 $8.06 Million - $11.6 Million	1,798,196 Added 170.21%	2,854,635 $13.6 Million
Q2 2022 Aug 03, 2022	BUY	$3.15 - $5.76 $3.33 Million - $6.09 Million	1,056,439 New	1,056,439 $4.75 Million
Q4 2021 Feb 10, 2022	SELL	$4.75 - $7.5 $12.2 Million - $19.2 Million	-2,562,935 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$5.02 - $6.59 $509,409 - $668,726	101,476 Added 4.12%	2,562,935 $14.5 Million
Q2 2021 Jul 20, 2021	BUY	$5.79 - $8.6 $14.3 Million - $21.2 Million	2,461,459 New	2,461,459 $16.2 Million
Q3 2019 Oct 21, 2019	SELL	$2.22 - $3.39 $1.29 Million - $1.96 Million	-579,210 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$1.8 - $3.3 $1.04 Million - $1.9 Million	-575,511 Reduced 49.84%	579,210 $1.25 Million
Q1 2019 May 02, 2019	BUY	$2.41 - $5.91 $321,932 - $789,469	133,582 Added 13.08%	1,154,721 $3.13 Million
Q4 2018 Feb 14, 2019	BUY	$3.94 - $9.7 $270,437 - $665,798	68,639 Added 7.21%	1,021,139 $4.9 Million
Q3 2018 Nov 07, 2018	BUY	$8.6 - $11.26 $2.22 Million - $2.91 Million	258,500 Added 37.25%	952,500 $9.02 Million
Q2 2018 Aug 14, 2018	BUY	$9.52 - $12.15 $952,000 - $1.22 Million	100,000 Added 16.84%	694,000 $6.75 Million
Q1 2018 May 09, 2018	BUY	$6.7 - $12.95 $160,800 - $310,800	24,000 Added 4.21%	594,000 $6.25 Million
Q3 2017 Nov 03, 2017	BUY	$5.4 - $8.47 $3.08 Million - $4.83 Million	570,000	570,000 $4.36 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account